Delivery Order SPE2DB24D2205-SPE2DB25FEFUB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 3, 2025, for the supply of Dexcom G6 Sensor 3S continuous glucose monitoring devices, valued at $1,467.90. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract and serves as a critical pharmaceutical and medical...
- The Defense Logistics Agency (DLA) awarded a $4,419.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3S continuous glucose monitoring devices on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's extensive role in supporting federal medical supply needs. The supplies will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,405.38 to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3S continuous glucose monitoring devices. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. The delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3S continuous glucose monitoring devices, valued at $2,442.88. This firm fixed-price delivery order, effective August 4, 2025, with completion by August 5, 2025, represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded without set-aside restrictions, indicating competitive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,273.18 to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3-packs on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1...
- The Defense Logistics Agency awarded a $1,304.80 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Dexcom G6 Sensor 3S continuous glucose monitoring devices. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of July 22, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,635.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 5, 2025, with a ceiling value of $1,260.46. This firm fixed-price delivery order, which is not set aside for small business or other categories, is scheduled for completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFUBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,482.65 to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3s, effective August 4, 2025, with completion by August 5, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary pharmaceutical distribution operations supporting federal medical procurement. This delivery order is issued under AmerisourceBergen's primary indefinite delivery vehicle with DLA Troop Support Medical (designated SPE2DX), valued at approximately $1 billion through December 2026. As a major pharmaceutical distributor and critical vendor for federal healthcare systems, AmerisourceBergen supplies a comprehensive range of medical products, medications, and specialized medical devices to support military and veteran healthcare programs. The Dexcom G6 continuous glucose monitoring sensor represents a specialized medical device component supporting diabetes management capabilities within the Defense Health Agency supply chain. The delivery order was awarded without set-aside designation on a firm fixed-price basis, consistent with AmerisourceBergen's established contracting patterns with DLA for medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/4/25 |